News

Neurophet to Participate in RSNA 2024: Unveiling Multiple Sclerosis Analysis Technology with Neurophet AQUA

Demonstrates MS Analysis Technology, Recently Secured FDA 510(k) ClearanceIntroduces 'Neurophet AQUA AD,' a Total Solution for Alzheimer's Disease Treatment Prescription,…

1 year ago

PULSEDATAAI ANNOUNCES APPOINTMENT OF TODD TYLER TO BOARD OF DIRECTORS

New board member brings significant experience in healthcare, strategy and technology advancement. NEW YORK, Dec. 5, 2024 /PRNewswire/ -- PulseDataAI,…

1 year ago

Avive Solutions and MedPro Associates Announce Strategic Partnership to Revolutionize Sudden Cardiac Arrest Response

SAN FRANCISCO, Dec. 5, 2024 /PRNewswire/ -- Avive Solutions, Inc., the innovator behind the next-generation Avive Connect AED®, today proudly…

1 year ago

Sage Secures $35 Million in Series B Funding to Transform Senior Living Operations Across the U.S. and Beyond

NEW YORK, Dec. 5, 2024 /PRNewswire/ -- Sage, the leading operations management platform for senior living, has raised $35 million…

1 year ago

SandboxAQ Publishes Scientific and Technical Milestones for Quantitative Methods

– Impact on biopharma, catalysts and novel materials– Joint paper with NVIDIA and other collaborators on computational chemistry speedup– Paper…

1 year ago

EXPERIENCE WELLNESS YEAR-ROUND WITH BEURER’S NEW SUNNY DAYLIGHT LAMPS

Whether at home or in the office, discover the uplifting power of sunlight in your daily routine to boost mood,…

1 year ago

meQuilibrium’s New State of the Workforce Study Reveals Key Obstacles to Workforce Change Readiness, Toll of Poorly Managed Psychosocial Risk

Study finds remote work no longer has considerable well-being advantages; Gen Z employees see change as normal–yet they aren't good…

1 year ago

SimX Receives $1.25M Phase II STTR Grant from AFWERX to Advance VR Training for Perioperative Expeditionary Medical Support

SAN JOSE, Calif., Dec. 5, 2024 /PRNewswire/ -- SimX announces it has been selected by AFWERX for a Phase II STTR…

1 year ago

Enjoin, LLC Appoints Healthcare Innovator Steve Hynes as Executive Chairman of its Board

Experienced Tech-Enabled Healthcare Services Executive Takes Leadership Role at Fast-Growing Revenue Integrity Company NASHVILLE, Tenn. and GREENWICH, Conn., Dec. 5,…

1 year ago

IceCure’s ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results

Data confirm previous results showing that ProSense® cryoablation is highly effective for kidney tumors < 3 cm and a safe…

1 year ago